APTOSE BIOSCIENCES INC. (APTOF) Operating cash flow 2017–2025
APTOSE BIOSCIENCES INC. (APTOF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$22.0MFY2025 · since FY2017: -$10.2M → -$22.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.0M | +38.9% |
| FY2024 | -$36.0M | +19.3% |
| FY2023 | -$44.6M | -38.0% |
| FY2022 | -$32.3M | +25.4% |
| FY2021 | -$43.3M | -27.8% |
| FY2020 | -$33.9M | -57.2% |
| FY2019 | -$21.6M | +7.1% |
| FY2018 | -$23.2M | -127.0% |
| FY2017 | -$10.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice